Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Companion Animal Postoperative Pain Management Therapeutics Market

Companion Animal Postoperative Pain Management Therapeutics Market Share

Report ID: GMI10730
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Companion Animal Postoperative Pain Management Therapeutics Market Share

The market is driven by continuous innovation and technological advancements. Leading companies in the market offer a diverse range of advanced pain management solutions, including medications and therapeutic interventions, aimed at alleviating postoperative pain in companion animals. These companies consistently invest in research and development to introduce new formulations and improve existing products, thereby enhancing efficacy and safety of treatments and to maintain a competitive edge in the market.

Companion Animal Postoperative Pain Management Therapeutics Market Companies

Few of the prominent players operating in companion animal postoperative pain management therapeutics industry include:

Assisi Animal Health
Bayer AG
Bimeda Animal Health
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Chanelle Pharma Group
Dechra Pharmaceuticals
Elanco Animal Health Incorporated
Merck Animal Health
Norbrook
SAVA Vet
Vetoquinol S.A.
Virbac Group
Zoetis Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global companion animal postoperative pain management therapeutics industry was valued at USD 133.5 million in 2023 and is anticipated to register 6.5% CAGR between 2024 and 2032, driven by the increasing prevalence of surgical procedures in companion animals.

The oral segment in the market accounted 57.1% revenue share in 2023 due to its convenience, ease of administration, and effective pain relief.

U.S. companion animal postoperative pain management therapeutics market accounted USD 59.2 million in 2023, driven by a combination of advanced veterinary care infrastructure and high pet ownership rates.

Assisi Animal Health, Bayer AG, Bimeda Animal Health, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals, Elanco Animal Health Incorporated, and Merck Animal Health, among others.